| GC33669-1mg |
|
51110-01-1 |
|
0 |
— |
|
|
|
| GC33668-100mg |
|
122306-11-0 |
Naspm (1-Naphthylacetyl spermine)
|
0 |
C22H34N4O |
|
|
|
| GC33668-50mg |
|
122306-11-0 |
Naspm (1-Naphthylacetyl spermine)
|
0 |
C22H34N4O |
|
|
|
| GC33668-10mg |
|
122306-11-0 |
Naspm (1-Naphthylacetyl spermine)
|
0 |
C22H34N4O |
|
|
|
| GC33668-5mg |
|
122306-11-0 |
Naspm (1-Naphthylacetyl spermine)
|
0 |
C22H34N4O |
|
|
|
| GC33668-10mM(1mLinDMSO) |
|
122306-11-0 |
Naspm (1-Naphthylacetyl spermine)
|
0 |
C22H34N4O |
|
|
|
| GC33667-50mg |
|
36396-99-3 |
N6-Cyclohexyladenosine (CHA)
|
0 |
C16H23N5O4 |
|
|
|
| GC33667-10mg |
|
36396-99-3 |
N6-Cyclohexyladenosine (CHA)
|
0 |
C16H23N5O4 |
|
|
|
| GC33667-10mM(1mLinDMSO) |
|
36396-99-3 |
N6-Cyclohexyladenosine (CHA)
|
0 |
C16H23N5O4 |
|
|
|
| GC33666-100mg |
|
106017-08-7 |
Rufloxacin hydrochloride (MF-934 hydrochloride)
|
0 |
C17H19ClFN3O3S |
|
|
|
| GC33666-50mg |
|
106017-08-7 |
Rufloxacin hydrochloride (MF-934 hydrochloride)
|
0 |
C17H19ClFN3O3S |
|
|
|
| GC33665-100mg |
|
12236-82-7 |
Procion Blue HB (Reactive Blue 2)
|
0 |
C29H20ClN7O11S3 |
|
|
|
| GC33665-50mg |
|
12236-82-7 |
Procion Blue HB (Reactive Blue 2)
|
0 |
C29H20ClN7O11S3 |
|
|
|
| GC33665-10mg |
|
12236-82-7 |
Procion Blue HB (Reactive Blue 2)
|
0 |
C29H20ClN7O11S3 |
|
|
|
| GC33665-10mM(1mLinDMSO) |
|
12236-82-7 |
Procion Blue HB (Reactive Blue 2)
|
0 |
C29H20ClN7O11S3 |
|
|
|
| GC33664-100mg |
|
74115-01-8 |
SKF-82958 hydrobromide ((±)-SKF 82958 hydrobromide)
|
0 |
C19H21BrClNO2 |
|
|
|
| GC33664-50mg |
|
74115-01-8 |
SKF-82958 hydrobromide ((±)-SKF 82958 hydrobromide)
|
0 |
C19H21BrClNO2 |
|
|
|
| GC33664-25mg |
|
74115-01-8 |
SKF-82958 hydrobromide ((±)-SKF 82958 hydrobromide)
|
0 |
C19H21BrClNO2 |
|
|
|
| GC33664-10mg |
|
74115-01-8 |
SKF-82958 hydrobromide ((±)-SKF 82958 hydrobromide)
|
0 |
C19H21BrClNO2 |
|
|
|
| GC33664-5mg |
|
74115-01-8 |
SKF-82958 hydrobromide ((±)-SKF 82958 hydrobromide)
|
0 |
C19H21BrClNO2 |
|
|
|
